Trials / Recruiting
RecruitingNCT01580982
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung and Other Thoracic Cancers
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The mechanisms of sensitivity and resistance to oncogene-targeted therapy can be determined from tumor tissue or tumor cell lines derived from available archival samples and/or from standard-of-care re-biopsy upon suspected tumor progression.
Detailed description
To identify baseline and treatment-related somatic changes in the tumor tissue from patients with lung and other thoracic cancers. To estimate the proportion of patients that subsequent therapy is altered based on the information acquired from such biopsies.
Conditions
Timeline
- Start date
- 2012-01-23
- Primary completion
- 2028-01-01
- Completion
- 2029-01-30
- First posted
- 2012-04-19
- Last updated
- 2026-02-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01580982. Inclusion in this directory is not an endorsement.